https://pharmadog.xyz/news/579127 pharmadog en 2026-10-22T21:57:11.000Z US Treasury drafts rules to curb American investment in Chinese biotech firms https://pharmadog.xyz/news/579043 pharmadog en 2026-10-22T21:04:40.000Z Merck and Moderna cancer vaccine data leak shows modest benefit, shares slide https://pharmadog.xyz/news/578851 pharmadog en 2026-10-22T20:00:07.000Z Pfizer and Valneva report mixed results for Lyme disease vaccine, with one analysis narrowly missing efficacy https://pharmadog.xyz/news/578707 pharmadog en 2026-10-22T19:48:07.000Z AbbVie’s HS drug lutikizumab meets Phase 3 goal but falls short of analyst expectations https://pharmadog.xyz/news/579250 pharmadog en 2026-10-22T19:42:00.000Z WinCo Foods recalls hoagie rolls after undisclosed sesame ingredient https://pharmadog.xyz/news/578747 pharmadog en 2026-10-22T19:27:00.000Z Moderna and Merck vaccine plus Keytruda cuts melanoma relapse risk by 42% in late-stage trial https://pharmadog.xyz/news/578727 pharmadog en 2026-10-22T19:03:31.000Z Moderna and Merck's mRNA melanoma vaccine cuts recurrence risk by 42% in trial https://pharmadog.xyz/news/578559 pharmadog en 2026-10-22T18:22:27.000Z AbbVie’s lutikizumab meets primary endpoint in Phase 3 hidradenitis trial but falls short of market expectations https://pharmadog.xyz/news/578560 pharmadog en 2026-10-22T18:04:47.000Z Nutrition experts urge White House to release ultra-processed food definition before midterms https://pharmadog.xyz/news/578283 pharmadog en 2026-10-22T17:52:09.000Z Top MAHA adviser Calley Means resigns from White House ahead of midterm elections https://pharmadog.xyz/news/578598 pharmadog en 2026-10-22T16:58:19.000Z FDA launches Neuroscience Advancement and Innovation Nexus to boost brain disorder drug development https://pharmadog.xyz/news/578071 pharmadog en 2026-10-22T16:32:24.000Z Roche prepares launch of breast cancer pill giredestrant amid patient anticipation https://pharmadog.xyz/news/578135 pharmadog en 2026-10-22T16:24:00.000Z FDA accepts new submission for Biohaven’s Vyglxia, opening path to approval https://pharmadog.xyz/news/578115 pharmadog en 2026-10-22T16:17:03.000Z Treasury rumored to consider rule limiting U.S. investment in Chinese biotech https://pharmadog.xyz/news/577903 pharmadog en 2026-10-22T15:51:50.000Z AMA chief urges regulators to keep pace with emerging AI-driven medical care https://pharmadog.xyz/news/577967 pharmadog en 2026-10-22T15:50:00.000Z Compounding pharmacy recalls copycat version of Eli Lilly’s Zepbound amid safety concerns https://pharmadog.xyz/news/577927 pharmadog en 2026-10-22T15:35:18.000Z Biohaven's ataxia drug resubmission accepted by FDA, shares surge 36% https://pharmadog.xyz/news/577968 pharmadog en 2026-10-22T15:20:26.000Z Roche reaffirms sales outlook despite weaker Xolair sales and looming generic competition https://pharmadog.xyz/news/577904 pharmadog en 2026-10-22T15:18:05.000Z Regulatory update: Hepatitis B hold lifted for Arbutus drug and Ultomiris receives accelerated approval https://pharmadog.xyz/news/577947 pharmadog en 2026-10-22T15:06:28.000Z Health policy crackdown warnings span from China to New York, says STAT newsletter https://pharmadog.xyz/news/134233 pharmadog en 2026-10-22T14:43:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/577760 pharmadog en 2026-10-22T14:12:38.000Z Biotech sector logs 31 IPOs in 2026, with four more slated, still far below 2021 boom https://pharmadog.xyz/news/577735 pharmadog en 2026-10-22T14:09:51.000Z AbbVie reports Phase 3 success for lutikizumab in painful skin disease, eyes FDA filing next year https://pharmadog.xyz/news/577736 pharmadog en 2026-10-22T14:07:13.000Z Sanofi breaks ground on new 36,000-sq-m insulin plant in Frankfurt https://pharmadog.xyz/news/577737 pharmadog en 2026-10-22T14:00:40.000Z GLP-1 drugs enter trials to test impact on alcohol and drug cravings https://pharmadog.xyz/news/577591 pharmadog en 2026-10-22T13:49:34.000Z FDA approves GSK-Ionis antisense drug Hibsago, opening functional-cure market for hepatitis B https://pharmadog.xyz/news/577611 pharmadog en 2026-10-22T13:42:46.000Z U.S. proposes rule tightening review of biotech licensing deals with Chinese firms https://pharmadog.xyz/news/577592 pharmadog en 2026-10-22T13:36:12.000Z Roche’s pipeline trim claims Poseida’s off-the-shelf CAR T asset https://pharmadog.xyz/news/577612 pharmadog en 2026-10-22T13:35:20.000Z Moderna and Merck prepare to unveil cancer vaccine data at ESMO Congress https://pharmadog.xyz/news/577613 pharmadog en 2026-10-22T13:17:29.000Z FDA issues final guidance on drug-related mobile applications https://pharmadog.xyz/news/577291 pharmadog en 2026-10-22T12:30:01.000Z Healthcare groups and tech firms debate FDA evidence requirements for generative AI medical devices https://pharmadog.xyz/news/577335 pharmadog en 2026-10-22T12:22:12.000Z U.S. health insurance premiums rise 9% as uninsured numbers climb, while telehealth firms explore GLP-1 drugs for addiction https://pharmadog.xyz/news/577292 pharmadog en 2026-10-22T12:00:26.000Z Redesign Health merges with ARC Global in $2B deal to help hospitals build startups https://pharmadog.xyz/news/577123 pharmadog en 2026-10-22T11:30:58.000Z Georgiamune to ship preclinical solid tumor drug to Menarini in deal up to $1.1 billion https://pharmadog.xyz/news/576979 pharmadog en 2026-10-22T10:51:29.000Z Investors Re-evaluate Kidney Disease as New Cell and Gene Therapy Strategies Emerge https://pharmadog.xyz/news/577879 pharmadog en 2026-10-22T10:39:00.000Z AbbVie’s lutikizumab meets primary endpoint in phase 3 hidradenitis suppurativa trial but falls short of competitive benchmarks https://pharmadog.xyz/news/576980 pharmadog en 2026-10-22T10:35:03.000Z Roivant's brepocitinib cuts steroid use in non-infectious uveitis in Phase 3 trials https://pharmadog.xyz/news/577880 pharmadog en 2026-10-22T10:29:00.000Z Celltrion licenses Kaigene's preclinical antibody KG013 in deal worth up to $580.5 million https://pharmadog.xyz/news/576955 pharmadog en 2026-10-22T10:21:48.000Z Roche touts strong Phase 3 track record while trimming pipeline amid peer setbacks https://pharmadog.xyz/news/577542 pharmadog en 2026-10-22T09:11:00.000Z Menarini's Stemline signs $1.1 billion deal to license Georgiamune's preclinical cancer immunotherapy https://pharmadog.xyz/news/576663 pharmadog en 2026-10-22T09:00:00.000Z Workers face 9% rise in family health insurance premiums in 2026, KFF survey shows https://pharmadog.xyz/news/576666 pharmadog en 2026-10-22T08:30:00.000Z Telehealth platforms prescribe GLP-1 drugs off-label for addiction, raising safety concerns https://pharmadog.xyz/news/576664 pharmadog en 2026-10-22T08:30:00.000Z Economist admits misreading ACA's cost-control promise and calls for reforms https://pharmadog.xyz/news/576665 pharmadog en 2026-10-22T08:30:00.000Z Family's unnamed inherited disease finally identified, offering hope for future generations https://pharmadog.xyz/news/577543 pharmadog en 2026-10-22T08:28:00.000Z Quest Diagnostics reports cyberattack that may have exposed patient records https://pharmadog.xyz/news/576930 pharmadog en 2026-10-22T05:28:00.000Z Rebranded Rezera plans IPO to fund phase 3 trial of NLRP3 inhibitor ruvonoflast for peripheral artery disease https://pharmadog.xyz/news/576594 pharmadog en 2026-10-22T04:21:00.000Z Roche CEO says stance on $1.5B Poseida acquisition unchanged despite dropping one CAR-T program https://pharmadog.xyz/news/575883 pharmadog en 2026-10-22T04:01:00.000Z Merck to showcase three late-stage TROP2 ADC trials at ESMO 2026, VP says payload is in the "Goldilocks zone" https://pharmadog.xyz/news/575884 pharmadog en 2026-10-22T04:01:00.000Z Key career moves that propelled three BioSpace 40 Under 40 honorees to biotech leadership https://pharmadog.xyz/news/575885 pharmadog en 2026-10-22T04:01:00.000Z Biopharma firms curb hiring as $100,000 H-1B visa fee limits foreign talent https://pharmadog.xyz/news/577881 pharmadog en 2026-10-22T02:33:00.000Z Abbott to separate Nutrition business into independent publicly traded company https://pharmadog.xyz/news/579370 pharmadog en 2026-10-22T00:00:00.000Z EMA opens consultation on platform trial methodology; MHRA to recognize CE-marked devices indefinitely https://pharmadog.xyz/news/579369 pharmadog en 2026-10-22T00:00:00.000Z FDA issues warning letters to Baxter and Olympus over GMP and QSR violations https://pharmadog.xyz/news/578757 pharmadog en 2026-10-22T00:00:00.000Z FDA approves GSK hepatitis B drug; EQT to acquire Qiagen for $10.8 billion https://pharmadog.xyz/news/574911 pharmadog en 2026-10-21T23:45:38.000Z Rezera files for IPO to fund NLRP3 peripheral artery disease program https://pharmadog.xyz/news/574803 pharmadog en 2026-10-21T23:19:30.000Z China biotech RiboX reports first human data for circular RNA therapies https://pharmadog.xyz/news/574511 pharmadog en 2026-10-21T21:38:41.000Z CMS expands fraud crackdown to New York adult day-care program, calls it a "plague to the state" https://pharmadog.xyz/news/574402 pharmadog en 2026-10-21T20:24:00.000Z Wedgewood Pharmacy recalls multiple compounded veterinary meds over potency testing inconsistencies https://pharmadog.xyz/news/574067 pharmadog en 2026-10-21T19:59:48.000Z ADA chief scientific officer Rita Kalyani departs amid ongoing review of New Orleans incident https://pharmadog.xyz/news/573855 pharmadog en 2026-10-21T18:48:02.000Z Treasury to tighten scrutiny of China biotech acquisitions under upcoming rules https://pharmadog.xyz/news/573731 pharmadog en 2026-10-21T17:49:31.000Z Isomorphic Labs' soaring valuation sparks debate over AI’s impact on drug development and healthcare costs https://pharmadog.xyz/news/573687 pharmadog en 2026-10-21T17:04:27.000Z Samsung Biologics union vows appeal after court blocks planned strike https://pharmadog.xyz/news/573435 pharmadog en 2026-10-21T16:49:10.000Z FDA cites Baxter’s inadequate oversight after repeated GMP violations at multiple plants https://pharmadog.xyz/news/573475 pharmadog en 2026-10-21T16:03:00.000Z GSK and Ionis receive FDA nod for Hibsago, a potential functional cure for chronic hepatitis B https://pharmadog.xyz/news/573307 pharmadog en 2026-10-21T15:31:00.000Z Roivant's brepocitinib shows strong Phase 3 results, paving way for uveitis indication https://pharmadog.xyz/news/573243 pharmadog en 2026-10-21T15:15:31.000Z Endpoints AI Day highlights agents, AI slop and biosecurity gaps in pharma https://pharmadog.xyz/news/573244 pharmadog en 2026-10-21T15:11:08.000Z CSL appoints former ViiV and GSK veteran Deborah Waterhouse as new CEO https://pharmadog.xyz/news/573075 pharmadog en 2026-10-21T14:57:33.000Z Alcon buys Neurotech for $550 million upfront https://pharmadog.xyz/news/573076 pharmadog en 2026-10-21T14:39:09.000Z Roivant's autoimmune drug brepocitinib succeeds in two pivotal trials, paving way for 2027 filing https://pharmadog.xyz/news/573119 pharmadog en 2026-10-21T14:24:45.000Z GSK receives FDA approval for hepatitis B therapy that expands functional cure rates https://pharmadog.xyz/news/573139 pharmadog en 2026-10-21T14:23:00.000Z Arcus kidney cancer drug shows stronger potency than Merck's Welireg, boosting shares https://pharmadog.xyz/news/572931 pharmadog en 2026-10-21T13:49:32.000Z Eight biopharma companies posting dozens of remote job openings https://pharmadog.xyz/news/572932 pharmadog en 2026-10-21T13:34:33.000Z US patients skip half of new high-cost drugs as prices surge past $250K https://pharmadog.xyz/news/572951 pharmadog en 2026-10-21T13:26:27.000Z Mark Cuban’s Cost Plus Drugs plans to enter custom rare-disease drug market https://pharmadog.xyz/news/572933 pharmadog en 2026-10-21T13:18:35.000Z Disc Medicine’s Phase 3 data revives rejected rare‑disease drug as China tightens biotech ownership rules https://pharmadog.xyz/news/572934 pharmadog en 2026-10-21T13:16:50.000Z FDA approves GSK‑Ionis hepatitis B functional cure, Hibsago, targeting undetectable virus after six months https://pharmadog.xyz/news/572783 pharmadog en 2026-10-21T12:05:54.000Z Roivant reports Lisraya beats placebo in Phase 3 trials for non-infectious uveitis https://pharmadog.xyz/news/572763 pharmadog en 2026-10-21T12:00:44.000Z Novo reports 25% average weight loss in women using CagriSema, with greatest loss in premenopausal patients https://pharmadog.xyz/news/572615 pharmadog en 2026-10-21T11:54:47.000Z Nigeria confirms travel-linked Ebola case tied to DRC outbreak https://pharmadog.xyz/news/123087 pharmadog en 2026-10-21T11:31:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/572295 pharmadog en 2026-10-21T10:12:55.000Z GSK and Ionis receive FDA nod for hepatitis B therapy promising functional cure https://pharmadog.xyz/news/573050 pharmadog en 2026-10-21T09:37:00.000Z Amid bepirovirsen triumph, GSK quietly scraps trial of next-gen hep B therapy https://pharmadog.xyz/news/572882 pharmadog en 2026-10-21T09:30:00.000Z Roche reports up to 30% shrinkage of chronic MS lesions with fenebrutinib, eyes FDA approval https://pharmadog.xyz/news/573052 pharmadog en 2026-10-21T09:16:00.000Z Astellas partners with AI Proteins on $400M computational drug discovery deal https://pharmadog.xyz/news/572003 pharmadog en 2026-10-21T08:30:00.000Z Experts suggest emphasizing measles survival rates to boost vaccine trust https://pharmadog.xyz/news/572006 pharmadog en 2026-10-21T08:30:00.000Z Rising US measles cases highlight need for door-to-door public health outreach https://pharmadog.xyz/news/572004 pharmadog en 2026-10-21T08:30:00.000Z Mark Cuban's Cost Plus Drugs targets rare disease market with custom n-of-1 therapies https://pharmadog.xyz/news/572007 pharmadog en 2026-10-21T08:30:00.000Z German biotech Immatics eyes pivotal Phase 3 readout after promising uveal melanoma cell therapy results https://pharmadog.xyz/news/572005 pharmadog en 2026-10-21T08:30:00.000Z NIH Scales Back Replication Initiative, Critics Warn It Undermines Scientific Rigor https://pharmadog.xyz/news/578994 pharmadog en 2026-10-21T06:41:00.000Z Merck and Moderna release early phase 3 melanoma vaccine data showing primary endpoint success but weaker secondary results https://pharmadog.xyz/news/571515 pharmadog en 2026-10-21T06:00:22.000Z Lilly advances retatrutide toward sleep-apnea market https://pharmadog.xyz/news/571203 pharmadog en 2026-10-21T04:12:00.000Z Crossover fundraisings may hit $4.2 billion in 2026, with 2025 rounds still leading historic totals https://pharmadog.xyz/news/571205 pharmadog en 2026-10-21T04:01:00.000Z Companies price the role, not the employee, says executive coach on compensation expectations https://pharmadog.xyz/news/571204 pharmadog en 2026-10-21T04:01:00.000Z US biotech M&A surges as Chinese licensing deals dominate 2026 market https://pharmadog.xyz/news/571934 pharmadog en 2026-10-21T03:13:00.000Z Biotech reverse mergers surge in 2026, reaching highest level since 2021 as PIPE financing spikes https://pharmadog.xyz/news/573392 pharmadog en 2026-10-21T02:18:00.000Z Myriad Genetics sells prenatal testing business to Labcorp for $210 million https://pharmadog.xyz/news/573393 pharmadog en 2026-10-21T02:11:00.000Z Hologic acquires Spain’s Reveal Genomics to expand breast cancer genomic testing https://pharmadog.xyz/news/574709 pharmadog en 2026-10-21T00:00:00.000Z Pharma companies push FDA for risk-based flexibility in container-closure testing guidance https://pharmadog.xyz/news/574710 pharmadog en 2026-10-21T00:00:00.000Z FDA device officials prioritize hiring after layoffs, express optimism for upcoming MDUFA VI agreement